CoChat
Sign Up
Cited by 149Alzheimer's disease research and treatmentsGinkgo biloba and Cashew ApplicationsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer’s disease

Liu, Xu, Hao, Wenlin, Qin, Yiren, Decker, Yann, Wang, Xuan, Burkart, Martin, Schötz, Karl, Menger, Michael D., Fassbender, Klaus, Liu, Yang·2015·Brain Behavior and Immunity
DOI 10.1016/j.bbi.2015.01.011
Open this paper in CoChat — free account

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease characterized by extracellular deposits of amyloid β peptide (Aβ) and microglia-dominated neuroinflammation. The therapeutic options for AD are currently limited. In this study, we investigated the antiinflammatory effects and the underlying molecular mechanisms of Ginkgo biloba extract EGb 761 when administered to TgCRND8 AD mice, which overexpress human Alzheimer's amyloid precursor protein (APP) specifically in neurons. We gave APP-transgenic mice EGb 761 as a dietary supplement for 2 or 5months. Plasma concentrations of EGb 761 components in mice were in the same range as such concentrations in humans taking EGb 761 at the recommended dose (240mg daily). Treatment with EGb 761 for 5months significantly improved the cognitive function of the mice as measured by the Barnes Maze test. It also attenuated the loss of synaptic structure proteins, such as PSD-95, Munc18-1, and SNAP25. Treatment with EGb 761 for 5months inhibited microglial inflammatory activation in the brain. The effects of treatment with EGb 761 for 2months were weak and not statistically significant. Moreover, EGb 761 activated autophagy in microglia. Treatment with EGb 761 decreased Aβ-induced microglial secretion of TNF-α and IL-1β and activation of caspase-1, both of which were abolished by the inhibition of autophagy. Treatment with EGb 761 also reduced the concentrations of NLRP3 protein that colocalized with LC3-positive autophagosomes or autolysosomes in microglia. Additionally, long-term treatment with EGb 761 may reduce cerebral Aβ pathology by inhibiting β-secretase activity and Aβ aggregation. Therefore, long-term treatment with G. biloba extract EGb 761, a clinically available and well-tolerated herbal medication, ameliorates AD pathology by antiinflammatory and Aβ-directed mechanisms.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2015.01.011

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 61 references

Cited by

Sorted by citations

Items 101–149 of 149

Related

See all

Metadata

Authors
Liu, X., Hao, W., Qin, Y., Decker, Y., Wang, X., Burkart, M., Schötz, K., Menger, M. D., Fassbender, K., & Liu, Y.
Affiliations
  • Saarland University (DE)
  • Soochow University (CN)
  • Dr Willmar Schwabe (Germany) (DE)
Corresponding author
  • Liu, Xu
  • Liu, Yang
ORCID
Venue
Brain Behavior and Immunity
Publisher
Elsevier BV
Published
2015-05
Volume
46
Pages
121-131
ISSN
0889-1591 (ISSN-L)
DOI
10.1016/j.bbi.2015.01.011
OpenAlex
W2032028277
Cited by
149
References
61
Citations by year
2026: 9 · 2025: 14 · 2024: 18 · 2023: 12 · 2022: 15 · 2021: 13 · 2020: 13 · 2019: 12 · 2018: 18 · 2017: 10 · 2016: 13 · 2015: 2
FWCI
10.56
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Willmar Schwabe GmbH & Co. KG
  • EU (211696)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Ginkgo biloba and Cashew Applications
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, Ginkgo biloba extract EGb 761, TgCRND8 mice, amyloid-beta, microglial neuroinflammation, autophagy, NLRP3 inflammasome, synaptic proteins, cognitive function, beta-secretase, amyloid fibril formation, herbal medicine, anti-inflammatory therapy
MeSH terms
Disks Large Homolog 4 Protein, Ginkgo Extract, Alzheimer Disease, Animals, Brain, Membrane Proteins, Mice, Transgenic, Neurons, Plant Extracts, Amyloid beta-Peptides, Neuroprotective Agents, Maze Learning, Ginkgo biloba, Synaptosomal-Associated Protein 25, Mice, Guanylate Kinases, Munc18 Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review